Evidence map›Paper›PMID 41498665›Full record

ArticleIndian journal of pharmacology2026

Carbamazepine-induced aplastic anemia: A rare reported adverse drug reaction.

Anjali Kushwah, Akhilesh Pratap Singh Tomar, Meghna Shinde, Preeti Acharya

Abstract readCase Reports
In one paragraph

Article in Indian journal of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anjali KushwahDepartment of Pharmacology, MGM Medical College, Indore, Madhya Pradesh, India.
Akhilesh Pratap Singh TomarDepartment of Microbiology, MGM Medical College, Indore, Madhya Pradesh, India.
Meghna ShindeDepartment of Pharmacology, MGM Medical College, Indore, Madhya Pradesh, India.
Preeti AcharyaDepartment of Pharmacology, MGM Medical College, Indore, Madhya Pradesh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractCarbamazepine is widely used drug for various neurological psychiatric disorders. Aplastic anemia is its rare serious adverse effect which possess high mortality rate. This is a retrospective case study where aplastic anemia due to carbamazepine was reported. We enquired the case details and on doing the causality assessment by World Health Organization scale, concluded it as a "certain" type of Adverse Drug Reaction (ADR) induced by carbamazepine. A 44-year-old male was taking carbamazepine prescribed for epilepsy for 2 years. For the last 4-5 months, he started having generalized weakness, easy fatiguability, shortness of breath on exertion, and pedal edema. Investigating it, further he was diagnosed with carbamazepine-induced aplastic anemia. Routine blood investigations, bone marrow findings, etiological confirmation done by treating physicians, and reporting of ADRs by pharmacologists through pharmacovigilance program may provide World Health Organization to release drug alerts so as to warrant the future use of culprit drugs.

Indexed as

Anemia, AplasticAnticonvulsantsCarbamazepineAdultEpilepsyHumansMaleAnticonvulsantsCarbamazepineAdverse drug reactionaplastic anemiacarbamazepine

Identifiers

PMID41498665
PMCPMC12875522

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.